Back to Search
Start Over
REALMA: Subset of patients with Marginal Zone Lymphomas from the French nationwide REALYSA real‐world prospective cohort.
- Source :
- Hematological Oncology; Jun2023 Supplement 1, Vol. 41, p387-388, 2p
- Publication Year :
- 2023
-
Abstract
- Regarding the B initial workup b , while at least one imagery was offered in 97% of patients, SP 18 sp FDG-PET/CT (EMZL 78%, SMZL 62%, NMZL 78%) was performed more frequently than CT-scan at baseline (EMZL 73%, SMZL 62%, NMZL 71%), although 47% patients underwent both procedures. Diagnosis of MZL was mostly evoked by general practitioners (48%) but patients were finally treated by hematologists (98%). B Background: b Marginal Zone Lymphomas (MZL) are a heterogeneous group of lymphomas that include three subtypes: extranodal MZL (EMZL), splenic MZL (SMZL) and nodal MZL (NMZL). [Extracted from the article]
- Subjects :
- LYMPHOMAS
NON-Hodgkin's lymphoma
Subjects
Details
- Language :
- English
- ISSN :
- 02780232
- Volume :
- 41
- Database :
- Complementary Index
- Journal :
- Hematological Oncology
- Publication Type :
- Academic Journal
- Accession number :
- 164231083
- Full Text :
- https://doi.org/10.1002/hon.3164_281